New shampoo for treating head lice
Part of Skin clinical trials.
This study tests a new shampoo to treat head lice. It is for people with mild to moderate lice and compares the new shampoo to a standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy and at least 2 years old (3 years old for one of the study groups).
- You or your child must currently have a mild to moderate head lice infestation (fewer than 25 live lice).
- Your hair must be short to mid-length (not longer than the shoulders) and can be straight, wavy, or curly up to a certain curl type (3C) — very tight curls (type 4A-4C) are not included.
- If you are a woman who could become pregnant, you must agree to use effective birth control and have a negative pregnancy test before starting.
- You must not be pregnant or nursing, and you cannot have used any anti-lice product in the past month.
- You must not have certain health conditions such as diabetes, immune problems, or scalp conditions like severe scratches or skin diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medical device for head lice compared to a standard anti-lice shampoo. It aims to see if the device is safe and works well for people with mild to moderate lice.
This trial tests a new head lice product (X92001483) to see how safe and effective it is compared to the standard treatment Nix. It looks at both getting rid of lice and preventing them from coming back.
This study compares a new lice lotion to a standard lice shampoo to see how well they work and if they are safe. If you or your child has head lice, participating could help find a better way to get rid of them.
This study tests a new antidandruff lotion designed to restore the natural balance of microbes on your scalp. If you have moderate to severe dandruff and are generally healthy, this trial may help improve your dandruff with a specially formulated product.
This study tests a new medication called nemolizumab for people with lichen planopilaris (LPP), a type of scarring hair loss. It aims to see if the drug can help reduce scalp itching and improve the condition.
This study tests a new experimental drug called PG-033 in healthy adults. It helps doctors find out if the drug is safe and how your body processes it at different dose levels.
Hear when a new Headlice trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.